Ayşegül Doğan Selected Research

Schiff Bases (Schiff Base)

2/2018	Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer.
2/2017	Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro.
1/2017	Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo.
11/2016	Schiff Base-Poloxamer P85 Combination Prevents Prostate Cancer Progression in C57/Bl6 Mice.
6/2015	A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayşegül Doğan Research Topics

Disease

7	Neoplasms (Cancer) 02/2019 - 12/2013
4	Inflammation (Inflammations) 03/2022 - 11/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2016
3	Wounds and Injuries (Trauma) 06/2016 - 12/2014
1	Hypoxia (Hypoxemia) 04/2022
1	Erythema 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Dermatitis 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019
1	Osteonecrosis (Kienbock's Disease) 02/2019
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 02/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Kidney Neoplasms (Kidney Cancer) 02/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2018
1	Invasive Fungal Infections 10/2017
1	Obesity 02/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Burns 11/2015
1	Infections 11/2015
1	Carcinoma (Carcinomatosis) 06/2015
1	Liver Neoplasms (Liver Cancer) 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 12/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 12/2013

Drug/Important Bio-Agent (IBA)

6	Poloxamer (Poloxamer 407)IBA 02/2018 - 12/2014
5	BoronIBA 01/2022 - 11/2015
5	Schiff Bases (Schiff Base)IBA 02/2018 - 06/2015
4	CopperIBA 02/2017 - 06/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 11/2015
3	Pharmaceutical PreparationsIBA 10/2017 - 11/2016
3	HydrogelsIBA 06/2016 - 12/2014
2	Apelin ReceptorsIBA 04/2022 - 02/2019
2	SolutionsIBA 02/2018 - 12/2014
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	CytoglobinIBA 03/2022
1	LipopolysaccharidesIBA 03/2022
1	NeuroglobinIBA 03/2022
1	GlobinsIBA 03/2022
1	Diphosphonates (Bisphosphonates)IBA 02/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	phenylpiperazineIBA 01/2019
1	ChemokinesIBA 01/2019
1	CytokinesIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 02/2017
1	Ethylene Oxide (Oxirane)IBA 02/2017
1	polypropylene glycol (poly(propylene oxide))IBA 02/2017
1	AndrogensIBA 02/2017
1	Hormones (Hormone)IBA 01/2017
1	Streptozocin (Streptozotocin)FDA Link 06/2016
1	AntigensIBA 11/2015
1	carboxypolymethyleneIBA 11/2015
1	UCON 50-HB-5100 (F127)IBA 11/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 06/2015
1	CollagenIBA 12/2014

Therapy/Procedure

3	Therapeutics 01/2019 - 12/2013
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 02/2017
1	Castration 01/2017